Dr Reddys Laboratories (RDY) Exchange Rate Effect (2009 - 2010)

Dr Reddys Laboratories (RDY) posted quarterly Exchange Rate Effect of $239.0 million for Q1 2010, up 1393.75% on a QoQ basis from $16.0 million in Q4 2009.

Dr Reddys Laboratories (RDY) Exchange Rate Effect (2009 - 2010) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Exchange Rate Effect for 2 consecutive years, with $239.0 million the latest figure, recorded in Q1 2010.

  • Quarterly Exchange Rate Effect changed N/A year-over-year to $239.0 million in Q1 2010, while the trailing twelve-month figure through Mar 2010 was $246.0 million (changed N/A YoY) and the FY2026 annual result came in at $13.0 million, up 1200.0% from the prior year.
  • Exchange Rate Effect rose to $239.0 million in Q1 2010 per RDY's latest filing, from $16.0 million in the prior quarter.
  • Over the last five years, Exchange Rate Effect for RDY reached as high as $239.0 million in Q1 2010 and fell as low as -$15.0 million in Q3 2009.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -17.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 17.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.01 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -4.20 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -5.00 Mn
10 Dr Reddys Laboratories 9.82 Bn 9.66 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2010 239.00 Mn
Mar 31, 2010 239.00 Mn
Dec 31, 2009 16.00 Mn
Dec 31, 2009 16.00 Mn
Sep 30, 2009 -15.00 Mn
Sep 30, 2009 -15.00 Mn
Jun 30, 2009 6.00 Mn
Jun 30, 2009 6.00 Mn